Roger E. McLendon mostly deals with Cancer research, Glioma, Pathology, Stem cell and Internal medicine. His Cancer research study combines topics in areas such as Mutation, IDH1, Phenotype and Epidermal growth factor receptor. His biological study spans a wide range of topics, including Tumor microenvironment, Cancer, O6-Benzylguanine, ATRX and Alkyltransferase.
Roger E. McLendon interconnects Viremia and Anaplastic astrocytoma, Astrocytoma, Oligodendroglioma in the investigation of issues within Pathology. His studies deal with areas such as Cancer cell and Immunology as well as Stem cell. His Internal medicine research focuses on Oncology and how it relates to Bevacizumab, Clinical endpoint and Molecular analysis.
His scientific interests lie mostly in Pathology, Glioma, Cancer research, Internal medicine and Oncology. Roger E. McLendon focuses mostly in the field of Pathology, narrowing it down to matters related to Monoclonal antibody and, in some cases, Antigen. His work carried out in the field of Glioma brings together such families of science as Survival rate, Molecular biology, IDH1 and Alkyltransferase.
The various areas that Roger E. McLendon examines in his Cancer research study include Mutation, Cancer, Epidermal growth factor receptor and Stem cell. His Mutation study results in a more complete grasp of Genetics. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Surgery.
The scientist’s investigation covers issues in Cancer research, Pathology, Glioma, Internal medicine and Cancer. His Cancer research research includes themes of CD155, Gene, DNA methylation and Immunotherapy. His Pathology research is multidisciplinary, incorporating elements of Pilocytic astrocytoma, Central neurocytoma and Ganglioglioma.
His Glioma research is multidisciplinary, relying on both Tumor microenvironment, IDH1, Brain tumor, Radioresistance and Regulation of gene expression. His Internal medicine research incorporates themes from Gastroenterology and Oncology. His Cancer research incorporates elements of Congenital cytomegalovirus infection and Family medicine.
His primary areas of study are Cancer research, Cancer, DNA methylation, Glioma and Gene. His Cancer research study incorporates themes from Mutation, Pathology, Chromatin, microRNA and Signal transduction. His work is dedicated to discovering how Mutation, Phenotype are connected with ATRX and other disciplines.
Roger E. McLendon has included themes like Congenital cytomegalovirus infection, Chemotherapy and Oncology in his Cancer study. Roger E. McLendon works in the field of Glioma, focusing on Astrocytoma in particular. His work on Carcinogenesis as part of general Gene study is frequently connected to Statistical analysis, Confusion and Characterization, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao;Qiulian Wu;Roger E McLendon;Yueling Hao.
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
D. Williams Parsons;Siân Jones;Xiaosong Zhang;Jimmy Cheng-Ho Lin.
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Roger McLendon;Allan Friedman;Darrell Bigner;Erwin G. Van Meir.
IDH1 and IDH2 Mutations in Gliomas
Hai Yan;D. Williams Parsons;Genglin Jin;Roger McLendon.
The New England Journal of Medicine (2009)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
Daniel J. Brat;Roel G.W. Verhaak;Kenneth D. Aldape;W. K.Alfred Yung.
The New England Journal of Medicine (2015)
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor
Shideng Bao;Qiulian Wu;Sith Sathornsumetee;Yueling Hao.
Cancer Research (2006)
Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
Zhizhong Li;Shideng Bao;Shideng Bao;Qiulian Wu;Qiulian Wu;Hui Wang.
Cancer Cell (2009)
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela;Zachary J. Reitman;Yuchen Jiao;Chetan Bettegowda.
Proceedings of the National Academy of Sciences of the United States of America (2013)
Altered Telomeres in Tumors with ATRX and DAXX Mutations
Christopher M. Heaphy;Roeland F. de Wilde;Yuchen Jiao;Alison P. Klein.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: